The Role of Complement Activation in Atherosclerosis
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Immunologic Research
- Vol. 30 (1), 073-080
- https://doi.org/10.1385/ir:30:1:073
Abstract
Atherosclerosis is a chronic inflammatory disease in which dyslipidemia, inflammation, and the immune system play an important pathogenetic role. A role in atherogenesis was demonstrated for monocyte/macrophages, complement system, and T-lymphocytes. Complement activation and C5b-9 deposition occurs both in human and experimental atherosclerosis. Complement C6 deficiency has a protective effect on diet-induced atherosclerosis, indicating that C5b-9 assembly is required for the progression of atherosclerotic lesions. The maturation of atherosclerotic lesions beyond the foam cell stage was shown to be strongly dependent on an intact complement system. C5b-9 may be responsible for cell lysis, and sublytic assembly of C5b-9 induces smooth muscle cell (SMC) and endothelial cell (EC) activation and proliferation. All these data suggest that activation of the complement system plays an important role in atherogenesis.Keywords
This publication has 63 references indexed in Scilit:
- Association Between Complement Factor H and Proteoglycans in Early Human Coronary Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Innate and acquired immunity in atherogenesisNature Medicine, 2002
- ApoE−/− Mice Develop Atherosclerosis in the Absence of Complement Component C5Biochemical and Biophysical Research Communications, 2001
- Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularizationJournal of Clinical Investigation, 1999
- Neovascularization in atherectomy specimens from patients with unstable angina: Implications for pathogenesis of unstable anginaAmerican Heart Journal, 1998
- Immunohistochemical Colocalization of the Terminal Complex of Human Complement and Smooth Muscle Cell α-Actin in Early Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Complement C5b-9 Increases Plasminogen Binding and Activation on Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- CD59 (homologous restriction factor 20), a plasma membrane protein that protects against complement C5b-9 attack, in human atherosclerotic lesionsAtherosclerosis, 1992
- Generation of complement anaphylatoxins and C5b-9 by crystalline cholesterol oxidation derivatives depends on hydroxyl group number and position☆Molecular Immunology, 1987
- COMPLEMENT AS A FACTOR IN ARTERIOSCLEROSISActa Pathologica Microbiologica Scandinavica Section A Pathology, 1970